We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
+21.78%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$1.71B
AUM Growth
+$237M
Cap. Flow
-$25M
Cap. Flow %
-1.46%
Top 10 Hldgs %
38.06%
Holding
168
New
15
Increased
68
Reduced
44
Closed
9

Top Buys

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$6.6M
2
CARR icon
Carrier Global
CARR
+$6.15M
3
JPM icon
JPMorgan Chase
JPM
+$6.09M
4
DAL icon
Delta Air Lines
DAL
+$5.99M
5
BKNG icon
Booking.com
BKNG
+$5.15M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$47.5M
2
BSX icon
Boston Scientific
BSX
+$12.4M
3
V icon
Visa
V
+$10M
4
MA icon
Mastercard
MA
+$3.62M
5
PEP icon
PepsiCo
PEP
+$3.57M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.51%
2 Technology 21.8%
3 Financials 15.23%
4 Healthcare 14.96%
5 Communication Services 11.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
26
Zoetis
ZTS
$31.9B
$15.6M 0.91%
94,329
-2,016
-2% -$328K
BLK icon
27
Blackrock
BLK
$175B
$14.3M 0.84%
19,863
+69
+0.3% +$45.8K
CB icon
28
Chubb
CB
$134B
$14.1M 0.83%
91,847
+264
+0.3% +$37K
CME icon
29
CME Group
CME
$94.4B
$14M 0.82%
76,751
REGN icon
30
Regeneron Pharmaceuticals
REGN
$78.3B
$13.7M 0.8%
28,424
+319
+1% +$172K
SHW icon
31
Sherwin-Williams
SHW
$87.8B
$13.7M 0.8%
55,908
-1,683
-3% -$399K
ONC
32
BeOne Medicines Ltd
ONC
$33.5B
$13.5M 0.79%
52,166
-11,823
-18% -$3.26M
MDLZ icon
33
Mondelez International
MDLZ
$79.2B
$13M 0.76%
222,524
PFE icon
34
Pfizer
PFE
$145B
$13M 0.76%
352,990
+2,951
+0.8% +$108K
ATVI
35
DELISTED
Activision Blizzard
ATVI
$12.8M 0.75%
137,457
SGEN
36
DELISTED
Seagen Inc. Common Stock
SGEN
$12.5M 0.73%
71,557
-11,300
-14% -$2.11M
GDDY icon
37
GoDaddy
GDDY
$11.3B
$11.5M 0.67%
139,008
SE icon
38
Sea Limited
SE
$68.3B
$11.5M 0.67%
57,565
+6,768
+13% +$1.21M
AMD icon
39
Advanced Micro Devices
AMD
$846B
$11.4M 0.67%
124,250
+2,451
+2% +$212K
PODD icon
40
Insulet
PODD
$11.6B
$11.3M 0.66%
44,083
DHR icon
41
Danaher
DHR
$137B
$11.1M 0.65%
56,596
-2,676
-5% -$537K
RARE icon
42
Ultragenyx Pharmaceutical
RARE
$2.54B
$11M 0.64%
79,742
+1,016
+1% +$121K
IDXX icon
43
Idexx Laboratories
IDXX
$46.4B
$11M 0.64%
21,914
CRSP icon
44
CRISPR Therapeutics
CRSP
$5.23B
$10.6M 0.62%
69,349
+916
+1% +$108K
AAPL icon
45
Apple
AAPL
$4.52T
$10.5M 0.62%
79,478
-7,622
-9% -$917K
HD icon
46
Home Depot
HD
$347B
$10.5M 0.61%
39,456
+7,870
+25% +$2.16M
BAC icon
47
Bank of America
BAC
$440B
$10.5M 0.61%
345,514
+246,144
+248% +$6.6M
TRMB icon
48
Trimble
TRMB
$13.9B
$10.3M 0.6%
154,516
NVCR icon
49
NovoCure
NVCR
$1.89B
$10.3M 0.6%
59,618
+824
+1% +$113K
TEL icon
50
TE Connectivity
TEL
$62.9B
$10.2M 0.6%
84,544
+1,570
+2% +$173K

Similar funds

Capital International's Q4 2020 Portfolio in Review

As of Q4 2020, Capital International held 168 positions worth $1.71B, up 16% from $1.48B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Capital International's Q4 2020 filing shows 15 new, 68 increased, 44 reduced and 9 closed positions. Its largest new stake was Delta Air Lines: 164,797 shares worth $6.63M. The largest sale was Tesla, an estimated $47.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

  • Capital International's largest Q4 2020 buy was Delta Air Lines: 164,797 shares worth $6.63M.
  • Capital International added most to Bank of America in Q4 2020, an estimated $6.6M increase.
  • Capital International's biggest Q4 2020 reduction was Tesla, cutting an estimated $47.5M.
  • Capital International fully exited PepsiCo in Q4 2020, selling an estimated $3.57M.
  • Capital International's ten largest holdings make up 38% of its $1.71B portfolio in Q4 2020.
  • Capital International opened 15 new positions and closed 9 in Q4 2020.
  • Capital International's portfolio value rose 16% quarter-over-quarter to $1.71B.

Based on Capital International's 13F filing for Q4 2020, filed 16 Feb 2021.